MedPath

FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

793

Active:72
Completed:193

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:10
Phase 2:25
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (335 trials with phase data)• Click on a phase to view related trials

Not Applicable
267 (79.7%)
Phase 2
25 (7.5%)
Phase 4
18 (5.4%)
Phase 3
12 (3.6%)
Phase 1
10 (3.0%)
Early Phase 1
2 (0.6%)
phase_1_2
1 (0.3%)

Youth Suicide Risk Factors, Reduction of Suicide Risk Factor in Youth People

Not Applicable
Not yet recruiting
Conditions
Mood Disorders
Suicide, Attempted
Suicidal Ideation
Suicide Prevention
First Posted Date
2025-09-23
Last Posted Date
2025-09-23
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
180
Registration Number
NCT07188506
Locations
🇮🇹

Fondazione Policlinico Universitario A. Gemelli IRCCS - UOC Psichiatria Clinica e d'Urgenza, Roma, RM, Italy

Starring Optical Coherence Tomography During Percutaneous Coronary Intervention Guidance

Active, not recruiting
Conditions
Acute Coronary Syndromes (ACS)
Chronic Coronary Syndrome
MINOCA
INOCA (Ischemia With Non Obstructive Coronary Artery Disease)
Percutaneous Coronary Intervention (PCI)
Coronary Stent Implantation
Stent Restenosis
Stent Thrombosis
Clinical Outcome
First Posted Date
2025-09-19
Last Posted Date
2025-09-19
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
3200
Registration Number
NCT07182799
Locations
🇮🇹

Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy

Motivational Interviewing Program on the Self-Care in Idiopathic Pulmonary Fibrosis

Not Applicable
Not yet recruiting
Conditions
Idiopathic Pulmonary Fibrosis (IPF)
First Posted Date
2025-09-18
Last Posted Date
2025-09-18
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
124
Registration Number
NCT07179562

Effects of Pasireotide Lar Therapy on Bone Metabolism

Recruiting
Conditions
Acromegaly Due to Pituitary Adenoma
Acromegaly
First Posted Date
2025-09-18
Last Posted Date
2025-09-18
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
120
Registration Number
NCT07179926
Locations
🇮🇹

Fondazione Policlinico Universitario Agostino Gemelli IRCCS UOC Endocrinologia e Diabetologia, Rome, RM, Italy

Analgesia Robotic Gynaecological Surgery

Completed
Conditions
Pain Management
First Posted Date
2025-09-12
Last Posted Date
2025-09-12
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
100
Registration Number
NCT07169604
Locations
🇮🇹

Fondazione Policlinico Universitario Policlinico Gemelli, Roma, RM, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 155
  • Next

News

EndoZip™ Automated Endoscopic System Shows 11.4% Weight Loss and Improved Comorbidities in Obesity Trial

Interim clinical data from the EndoZip™ automated endoscopic suturing system demonstrated an average total body weight loss of 11.4% at twelve months in patients with class I and II obesity.

Secure Multiparty Computation Enables Privacy-Friendly Evaluation of Patient Data in Adrenal Gland Metastasis Study

A bicenter, prospective, longitudinal observational study utilized MR-guided radiotherapy (MRgRT) to treat adrenal gland metastasis, emphasizing precision and minimizing radiation exposure.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.